Study on Skin Toxicities Induced by Cancer Treatments (DERMACLIC)

Institut Curie

Status: Completed

Conditions: Breast Cancer; Solid Tumor, Adult; Lung Cancer

Treatments: Other: Evaluation on skin toxicities

Study type: Interventional

Funder types: Other

Identifiers

NCT04402606

2019-A0872-55

Details and patient eligibility

About

The skin toxicities will be evaluated on patient (male or female) with an indication of cancer treatment in the case of solid tumor of the breast, or lung.

Enrollment: 292 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patient, male or female, aged 18 years and older, with a solid tumor breast or lung, localized, locally advanced or not, metastatic or not;
2. Patient in medical oncology consultation requiring systemic anti-tumor therapy (chemotherapy, targeted therapy, hormone therapy, immunotherapy) in neo-adjuvant, adjuvant or metastatic;
3. Treatment planned for a minimum period of 3 months (from the date of inclusion);
4. Having a social security protection;
5. Signed informed consent form of the study.

Exclusion criteria

1. Patient treated for lymphoma, leukemia or inflammatory breast cancer ;
2. Patient with a solid tumour which location is other than breast or lung;
3. Patient with a tumor wound ;
4. Patient with a general condition > 2 at baseline (ECOG classification) ;
5. Patient receiving anti-tumor treatment with radiotherapy exclusively or associated with concomitant radiotherapy ;
6. Patient unable to receive information about the study and to give consent ;
7. Persons deprived of liberty or guardianship ;
8. Impossible submission to study procedures for geographical or psychological reasons.

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

292 participants in 1 patient group

Evaluation on skin toxicities

Experimental group

Description:

This evaluation consists on a clinical examination of the skin and the realization of the cutaneous measurements of reference on 4 sites frequently exposed to the cutaneous toxicities: face, neckline, palms of the hands and soles of the feet.

Treatment:

Other: Evaluation on skin toxicities